Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

PHASE3CompletedINTERVENTIONAL

Enrollment

861

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Conditions

Allergic Conjunctivitis

Interventions

DRUG

Bepreve

One drop, both eyes, twice a day

DRUG

Placebo

One drop, both eyes, twice a day

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00586625 - Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers | Biotech Hunter | Biotech Hunter